Envveno Medical Corp (NVNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,754 | 3,620 | 4,555 | 54,728 | 9,335 |
| Marketable Securities | 41,399 | 42,792 | 34,489 | 0 | N/A |
| TOTAL | $43,734 | $46,923 | $39,436 | $55,040 | $9,569 |
| Non-Current Assets | |||||
| PPE Net | 182 | 334 | 521 | 618 | 399 |
| Other Non-Current Assets | 1,038 | 1,378 | 1,704 | 2,041 | 570 |
| TOTAL | $1,220 | $1,712 | $2,225 | $2,659 | $969 |
| Total Assets | $44,954 | $48,635 | $41,661 | $57,699 | $10,538 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,731 | 1,033 | 1,216 | 560 | 1,390 |
| Accrued Expenses | N/A | N/A | N/A | 729 | 1,169 |
| TOTAL | $2,095 | $1,371 | $1,530 | $1,580 | $3,186 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 700 | 1,064 | 1,402 | 1,715 | 254 |
| TOTAL | $700 | $1,064 | $1,402 | $1,715 | $254 |
| Total Liabilities | $2,795 | $2,435 | $2,932 | $3,295 | $3,440 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 17,536 | 13,317 | 9,472 | 9,470 | 8,504 |
| Retained earnings | -151,855 | -130,036 | -106,520 | -81,851 | -65,323 |
| TOTAL | $42,159 | $46,200 | $38,729 | $54,404 | $7,098 |
| Total Liabilities And Equity | $44,954 | $48,635 | $41,661 | $57,699 | $10,538 |